Antagonistic effect of Na+ and Mg2+ on P2z purinoceptor-associated pores in dibutyryl cyclic AMP-differentiated NG108-15 cells

J Neurochem. 1996 Oct;67(4):1694-701. doi: 10.1046/j.1471-4159.1996.67041694.x.

Abstract

The effect of replacement of extracellular Na+ with N-methyl-D-glucamine (NMG) on P2 receptor signaling pathways was investigated in dibutyryl cyclic AMP-differentiated NG108-15, cells. Benzoylbenzoic ATP (BzATP) dose-dependently increased the cytosolic Ca2+ concentration ([Ca2+]i) with an EC50 value of 230 microM. Replacement of Na+ with NMG as well as removal of Mg2+ from the bathing buffer potentiated ethidium bromide uptake, [Ca2+]i increase, and 45Ca2+ uptake in response to ATP or BzATP. In contrast, in the presence of 5 mM Mg2+ to limit the amount of ATP4-, replacement of Na+ with NMG had no effect on the ATP-induced [Ca2+]i increase but caused a markedly larger [Ca2+]i increase when the calculated concentration of ATP4- was > 10 microM. The calculated EC50 value for ATP4- stimulation of the [Ca2+]i increase was 23 microM in NG108-15 cells. In vascular smooth muscle cells, intracellular Ca2+ release was the major pathway for the ATP-induced [Ca2+]i increase; both removal of Mg2+ and replacement of Na+ with NMG did not affect the action of ATP. These data suggest that ATP(4-)-promoted pores are antagonized by Na+ and Mg2+ in dibutyryl cyclic AMP-differentiated NG108-15 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives*
  • Adenosine Triphosphate / pharmacology
  • Affinity Labels
  • Animals
  • Aorta
  • Bucladesine / pharmacology*
  • Calcium / metabolism
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Ethidium
  • Glioma
  • Hybrid Cells
  • Kinetics
  • Magnesium / pharmacology*
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology*
  • Neuroblastoma
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2 / metabolism*
  • Sodium / pharmacology*
  • Swine

Substances

  • Affinity Labels
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2
  • 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate
  • Bucladesine
  • Adenosine Triphosphate
  • Sodium
  • Ethidium
  • Magnesium
  • Calcium